...
首页> 外文期刊>Influenza and other respiratory viruses. >Comparisons of oseltamivir‐resistant (H275Y) and concurrent oseltamivir‐susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009
【24h】

Comparisons of oseltamivir‐resistant (H275Y) and concurrent oseltamivir‐susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008–2009

机译:2008-2009年住院成人抗奥司他韦(H275Y)和奥司他韦敏感性季节性季节性流感A(H1N1)病毒感染的比较

获取原文
           

摘要

AbstractIn an observational cohort study, we found that adults hospitalized for oseltamivir-resistant (H275Y) seasonal H1N1 influenza (n = 46) were older than those infected with oseltamivir-susceptible strains (n = 31) [74(IQR 59–83) versus 64(IQR 48–76) years; P = 0·045], and most had major comorbidities (78% versus 65%). Disease severity and clinical outcomes were comparable between the two groups: radiographic pneumonia 40–42%, supplemental oxygen use 47–48%, critical illness 11–13%, median duration of hospitalization 5–6 days, death rate 6–9%. Failure to receive effective antiviral therapy was associated with progression to critical illness (23% versus 0%, P = 0·016) and death (20% versus 0%, P = 0·033) in hospitalized patients with seasonal H1N1 influenza.
机译:摘要在一项观察性队列研究中,我们发现因奥司他韦耐药(H275Y)季节性H1N1流感住院(n = 46)的成年人比被奥司他韦敏感菌株(n = 31)感染的成年人[74(IQR 59-83)与64(IQR 48-76)年; P = 0·045],大多数合并症很严重(78%比65%)。两组之间的疾病严重程度和临床结果相当:放射线性肺炎40-42%,补充氧气使用47-48%,危重疾病11-13%,中位住院时间5-6天,死亡率6-9%。在季节性H1N1流感住院患者中,未能接受有效的抗病毒治疗与进展为重症疾病(23%vs 0%,P = 0.016)和死亡(20%vs 0%,P = 0.033)有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号